Bloodstream Infection Articles & Analysis
34 news found
Klebsiella is described by the Centers for Disease Control and Prevention (CDC) as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. ...
Some species of Fusarium can also cause a host of infections. People with healthy immune systems may develop infections of the nails or cornea. ...
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. ...
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. ...
Their newest production discusses Klebsiella, a type of gram-negative bacteria that can cause various healthcare-associated infections (HAIs). “HAIs due to Klebsiella can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis,” said Paul Cochrane, President of Cochrane & ...
Daptomycin is an essential antibiotic used in the treatment of serious bacterial infections, including skin and bloodstream infections. With its potent bactericidal activity against Gram-positive pathogens, Daptomycin has been a crucial treatment option for healthcare professionals around the world. ...
It has quickly become a cause of severe infections around the world, including in the United States according to the Centers for Disease Control and Prevention (CDC). ...
CDC reported that this fungus poses a unique challenge to public health because it can cause invasive and often deadly infections that can be resistant to multiple antifungal drugs, and that it is particularly concerning because it can spread to other patients. ...
The rationale for this program is based in part on published clinical evidence from Seres’ collaborators at Memorial Sloan Kettering Cancer Center showing that allogeneic HSCT patients with decreased diversity of commensal microbes are significantly more likely to die due to infection and/or lethal GvHD. SER-155 was developed using Seres’ reverse translational ...
“These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” said Matthew Henn, Ph.D., Chief Scientific Officer at Seres. ...
“Microbiome-based therapeutics have the potential to protect medically compromised transplant patients from life-threatening infections and GvHD as they start on their road to recovery,” said Matthew Henn, PhD, Chief Scientific Officer at Seres and co-author. ...
SER-109 is an investigational oral microbiome therapeutic for the prevention of recurrentC. difficile infection (rCDI). With an oral and poster presentation, Seres will present data on how SER-109 restores the functionality of the microbiome in a rapid and durable manner, which further supports the potential of microbiome therapeutics. ...
SER-155 is an investigational oral, rationally designed, cultivated microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bloodstream infections, and GvHD in patients receiving allo-HSCT. ...
This QDIP designation applies to the use of BTX 1901 to potentially ‘reduce the risk of Staph. aureus bloodstream infections in colonised patients dependent on central venous catheters for hemodialysis’, the lead indication for our novel intranasal gel. ...
Blood culture is the gold standard for detecting blood stream infections, including sepsis. An estimated 58 million are performed each year.2 A reduction in blood culture contamination rate from 3% to 1% equates to approximately 1.2 million fewer patients impacted by a potential misdiagnosis of sepsis. ...
These conferences and journals include the Emergency Nurses Association (ENA), Association for Professionals in Infection Control (APIC), Society for Healthcare Epidemiology of America (SHEA), American Journal of Medical Quality, Journal of Hospital Infection, American Journal of Infection Control, and Journal of Emergency Nursing. ...
” Blood cultures tests are essential to diagnose bloodstream infections including sepsis, determine the specific pathogen causing the infection, and target appropriate antimicrobial therapy to treat the patient. ...
” Blood cultures are essential in diagnosing bloodstream infections, including sepsis, identifying the specific pathogen causing the infection and, based on the results, determining what type of antimicrobial is appropriate to treat the patient. ...
A summary of the abstracts are as follows: The REMOVE (“Revealing Mechanisms and Investigating Efficiency Of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients with Infective Endocarditis“) investigator initiated randomized, controlled trial enrolled 288 patients with documented infective endocarditis with a EuroSCORE II ...
In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality Interim Data From Multicenter Study Highlight the Real-World Clinical Utility of Fast Phenotypic Antimicrobial Susceptibility Testing for BSI Across Diverse Healthcare Settings and Patient Populations Accelerate ...